Kavanagh sponsored legislation on July 7, 2026, aimed at strengthening FDA oversight, noting that Kessler was a former FDA Commissioner.
2 reports, 2 independent
Updated Aug 9
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kavanagh sponsored legislation on July 7, 2026, aimed at strengthening FDA oversight, noting that Kessler was a former FDA Commissioner.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- EWG reported that 99% of chemicals have avoided FDA scrutiny, highlighting issues with regulatory oversight.Sub-event
Legislation introduced to strengthen FDA oversight, involving a current sponsor and a former commissioner.1 source
Keep exploring
The entities involved
- FDA
-
Kavanagh
association football player
Nothing else this week.
-
Kessler
German badminton player
Nothing else this week.
Related events
- The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.